Sorry, you need to enable JavaScript to visit this website.
The recent Alfamino recall does not impact the United States. Alfamino and all other Nestlé products in the U.S. are safe to consume. Learn more

Oncology

Oncology

According to the National Cancer Institute, up to 85% of patients with cancer experience malnutrition during their treatment, which can lead to increased treatment toxicities and reduced quality of life. Further, up to 20% of mortality in patients with cancer is attributed to malnutrition.1

Nestlé Health Science's expertise in nutrition for oncology focuses on developing personalized nutrition solutions that help manage cancer-related malnutrition, support the immune system, and improve quality of life for patients undergoing cancer treatment.

Discover More

Oncology

Oncology

According to the National Cancer Institute, up to 85% of patients with cancer experience malnutrition during their treatment, which can lead to increased treatment toxicities and reduced quality of life. Further, up to 20% of mortality in patients with cancer is attributed to malnutrition.1

Nestlé Health Science's expertise in nutrition for oncology focuses on developing personalized nutrition solutions that help manage cancer-related malnutrition, support the immune system, and improve quality of life for patients undergoing cancer treatment.

Discover More

1. PDQ® Supportive and Palliative Care Editorial Board. PDQ Nutrition in Cancer Care. Bethesda, MD: National Cancer Institute. Updated: Jun.22, 2023. Available at: https://www.cancer.gov/about-cancer/treatment/side-effects/appetite-loss/nutrition-hp-pdq. Accessed: July 25, 2023. [PMID: 26389293]

2. American Cancer Society. (2021). Nutrition for people with cancer. https://www.cancer.org/treatment/survivorship-during-and-after-treatment/staying-active/nutrition/nutrition-during-treatment.html.